SUMOylation of GTF2IRD1 Regulates Protein Partner Interactions and Ubiquitin-Mediated Degradation

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Widagdo, Jocelyn ^a,b   Taylor, Kylie M ^a   Gunning, Peter W ^a   Hardeman, Edna C ^a   Palmer, Stephen J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; LYSINE; PROTEIN GTF2IRD1; PROTEIN PIASX BETA; PROTEIN UBC9; PROTEIN ZMYM5; REGULATOR PROTEIN; TRANSCRIPTION FACTOR GAL4; UBIQUITIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENETIC CONSERVATION; HUMAN; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING; SITE DIRECTED MUTAGENESIS; SUMOYLATION; UBIQUITINATION; UPREGULATION; WESTERN BLOTTING;

AMINO ACID MOTIFS; BINDING SITES; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; LYSINE; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; NUCLEAR PROTEINS; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEOLYSIS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, PROTEIN; SUMOYLATION; TRANS-ACTIVATORS; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN; UBIQUITIN-CONJUGATING ENZYMES;

EID: 84869069209     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049283     Document Type: Article

References (43)

1. Greeberg F, (1990) Williams syndrome professional symposium. Am J Med Genet Suppl 6: 85-88.
2. Stromme P, Bjornstad PG, Ramstad K, (2002) Prevalence estimation of Wililams syndrome. J Child Neurol 17: 269-271.
3. Osborne LR, Mervis CB, (2007) Rearrangements of the Williams-Beuren syndrome locus: molecular basis and implications for speech and language development. Expert Rev Mol Med 9: 1-16.
4. Antonell A, Del Campo M, Magano LF, Kaufmann L, de la Iglesia JM, et al. (2010) Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile. J Med Genet 47: 312-320.
5. Hirota H, Matsuoka R, Chen XN, Salandanan LS, Lincoln A, et al. (2003) Williams Syndrome deficits in visual spatial processing linked to GTF2IRD1 and GTF2I on chromosome 7q11.23. Genet Med 5: 311-321.
6. Karmiloff-Smith A, Grant J, Ewing S, Carette MJ, Metcalfe K, et al. (2003) Using case study comparisons to explore genotype-phenotype correlations in Williams-Beuren syndrome. J Med Genet 40: 136-140.
7. Morris CA, Mervis CB, Hobart HH, Gregg RG, Bertrand J, et al. (2003) GTF2I hemizygosity implicated in mental retardation in Williams syndrome: Genotype-phenotype analysis of five families with deletions in the Williams syndrome region. Am J Med Genet 123A: 45-59.
8. Tassabehji M, Hammond P, Karmiloff-Smith A, Thompson P, Thorgeirsson SS, et al. (2005) GTF2IRD1 in craniofacial development of humans and mice. Science 310: 1184-1187.
9. Young E, Lipina T, Tam E, Mandel A, Clapcote S, et al. (2008) Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice. Genes, Brain and Behavior 7: 224-234.
10. Howard ML, Palmer SJ, Taylor KM, Arthurson GJ, Spitzer MW, et al. (2012) Mutation of Gtf2ird1 from the Williams-Beuren syndrome critical region results in facial dysplasia, motor dysfunction, and altered vocalisations. Neurobiol Dis 45: 913-922.
11. Hinsley TA, Cunliffe P, Tipney HJ, Brass A, Tassabehji M, (2004) Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. Protein Sci 13: 2588-2599.
12. Bernier-Villamor V, Sampson DA, Matunis MJ, Lima CD, (2002) Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell 108: 345-356.
13. Johnson ES, Gupta AA, (2001) An E3-like factor that promotes SUMO conjugation to the yeast septins. Cell 106: 735-744.
14. Ouyang J, Gill G, (2009) SUMO engages multiple corepressors to regulate chromatin structure and transcription. Epigenetics 4: 1-5.
15. Geiss-Friedlander R, Melchior F, (2007) Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 8: 947-956.
16. Song J, Durrin LK, Wilkinson TA, Krontiris TG, Chen Y, (2004) Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc Natl Acad Sci U S A 101: 14373-14378.
17. Minty A, Dumont X, Kaghad M, Caput D, (2000) Covalent Modification of p73α by SUMO-1. Journal of Biological Chemistry 275: 36316-36323.
18. Sun H, Leverson JD, Hunter T, (2007) Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins. EMBO J 26: 4102-4112.
19. Tussie-Luna MI, Michel B, Hakre S, Roy AL, (2002) The SUMO ubiquitin-protein isopeptide ligase family member Miz1/PIASxbeta/Siz2 is a transcriptional cofactor for TFII-I. J Biol Chem 277: 43185-43193.
20. Zhao Y, Kwon SW, Anselmo A, Kaur K, White MA, (2004) Broad spectrum identification of cellular small ubiquitin-related modifier (SUMO) substrated proteins. J Biol Chem 279: 20999-21002.
21. Ganesan AK, Kho Y, Kim SC, Chen Y, Zhao Y, et al. (2007) Broad spectrum identification of SUMO substrates in melanoma cells. Proteomics 7: 2216-2221.
22. Gocke CB, Yu H, Kang J, (2005) Systematic Identification and Analysis of Mammalian Small Ubiquitin-like Modifier Substrates. Journal of Biological Chemistry 280: 5004-5012.
23. Hinsley TA, Cunliffe P, Tipney HJ, Brass A, Tassabehji M, (2004) Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. Protein Sci 13: 2588-2599.
24. Tay ES, Guven KL, Subramaniam N, Polly P, Issa LL, et al. (2003) Regulation of alternative splicing of Gtf2ird1 and its impact on slow muscle promoter activity. Biochem J 374: 359-367.
25. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR, (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51-59.
26. Perdomo J, Verger A, Turner J, Crossley M, (2005) Role for SUMO Modification in Facilitating Transcriptional Repression by BKLF. Mol Cell Biol 25: 1549-1559.
27. Gietz RD, Woods RA, (2002) Transformation of yeast by LiAc/SS carrier DNA/PEG Method. Methods in Enzymology 35: 87-96.
28. Palmer SJ, Santucci N, Widagdo J, Bontempo SJ, Taylor KM, et al. (2010) Negative autoregulation of GTF2IRD1 in Williams-Beuren Syndrome via a novel DNA binding mechanism. J Biol Chem 285: 4715-4724.
29. Vullhorst D, Buonanno A, (2003) Characterisation of general transcription factor 3, a transcription factor involved in slow muscle-specific gene expression. J Biol Chem 278: 8370-8379.
30. Su HL, Li SS, (2002) Molecular features of human ubiquitin-like SUMO genes and their encoded proteins. Gene 296: 65-73.
31. Kotaja N, Karvonen U, Jänne OA, Palvimo JJ, (2002) PIAS Proteins Modulate Transcription Factors by Functioning as SUMO-1 Ligases. Molecular and Cellular Biology 22: 5222-5234.
32. Smedley D, Hamoudi R, Lu YJ, Cooper C, Shipley J, (1999) Cloning and mapping of members of the MYM family. Genomics 60: 244-247.
33. Sohal J, Reiter A, Goldman J, Cross N, (2000) Cloning of ZNF237, a novel member of the MYM gene family that maps to human chromosome 13q11→q12. Cytogenet Cell Genet 89: 24-28.
34. Hecker CM, Rabiller M, Haglund K, Bayer P, Dikic I, (2006) Specification of SUMO1- and SUMO2-interacting motifs. J Biol Chem 281: 16117-16127.
35. Perry JJ, Tainer JA, Boddy MN, (2008) A SIM-ultaneous role for SUMO and ubiquitin. Trends Biochem Sci 33: 201-208.
36. Mackay JP, Crossley M, (1998) Zinc fingers are sticking together. Trends Biochem Sci 23: 1-4.
37. Hakimi M-A, Dong Y, Lane WS, Speicher DW, Shiekhattar R, (2003) A Candidate X-linked Mental Retardation Gene Is a Component of a New Family of Histone Deacetylase-containing Complexes. J Biol Chem 278: 7234-7239.
38. Wen Y-D, Perissi V, Staszewski LM, Yang W-M, Krones A, et al. (2000) The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc of Nat Acad Sci USA 97: 7202-7207.
39. Wen YD, Cress WD, Roy AL, Seto E, (2003) Histone deacetylase 3 binds to and regulates the multifunctional transcription factor TFII-I. J Biol Chem 278: 1841-1847.
40. Tussie-Luna MI, Bayarsaihan D, Seto E, Ruddle FH, Roy AL, (2002) Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxb. Proc Natl Acad Sci USA 99: 12807-12812.
41. Gocke CB, Yu H, (2008) ZNF198 stabilizes the LSD1-CoREST-HDAC1 complex on chromatin through its MYM-type zinc fingers. PLoS ONE 3: e3255.
42. Sharrocks AD, (2006) PIAS proteins and transcriptional regulation-more than just SUMO E3 ligases? Genes Dev 20: 754-758.
43. Deshaies RJ, Joazeiro CA, (2009) RING domain E3 ubiquitin ligases. Annu Rev Biochem 78: 399-434.